Guanfacine NDC 0904-7140

NDC codes

FDA NDC Directory

Product NDC (as listed)0904-7140Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00904-7140Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0904-7140-04	00904714004	30 BLISTER PACK in 1 CARTON (0904-7140-04) / 1 TABLET in 1 BLISTER PACKMarketed from Dec 2, 2013

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Guanfacine
Generic name (nonproprietary): guanfacine
Active ingredients: Guanfacine hydrochloride — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Major Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074673
Marketing start: Dec 2, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 0904-7140_eaf671db-1fc7-4923-af07-99aea483d91aSPL ID eaf671db-1fc7-4923-af07-99aea483d91aSPL set ID 400be431-ad6c-4783-a513-ca8b47bf43eeRxCUI 197745UNII PML56A160O
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400904714004 followed by a unit qualifier and the quantity

Package 00904-7140-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 4, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Guanfacine hydrochloride tablets are indicated in the management of hypertension. Guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074673

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074673
Product	Strength	Form · route	Labeler	Product NDC
Guanfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	Epic Pharma, LLC	42806-296
Guanfacine	Guanfacine hydrochloride 1 mg/1	TabletOral	Proficient Rx LP	63187-302
Guanfacine	Guanfacine hydrochloride 1 mg/1	TabletOral	PuraCap Laboratories LLC dba Blu Pharmaceuticals	24658-730
Guanfacine	Guanfacine hydrochloride 1 mg/1	TabletOral	Epic Pharma, LLC	42806-048